Genitsaridi, I. Flouri, I. Plexousakis, D. Marias, K. Boki, K. Skopouli, F. Drosos, A. Bertsias, G. Boumpas, D. Sidiropoulos, P., Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group, Arthritis Research and Therapy, (22), 2020, BioMed Central Ltd.,